270 related articles for article (PubMed ID: 27593106)
1. Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.
Raggi C; Correnti M; Sica A; Andersen JB; Cardinale V; Alvaro D; Chiorino G; Forti E; Glaser S; Alpini G; Destro A; Sozio F; Di Tommaso L; Roncalli M; Banales JM; Coulouarn C; Bujanda L; Torzilli G; Invernizzi P
J Hepatol; 2017 Jan; 66(1):102-115. PubMed ID: 27593106
[TBL] [Abstract][Full Text] [Related]
2. Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies.
Hong JH; Yong CH; Heng HL; Chan JY; Lau MC; Chen J; Lee JY; Lim AH; Li Z; Guan P; Chu PL; Boot A; Ng SR; Yao X; Wee FYT; Lim JCT; Liu W; Wang P; Xiao R; Zeng X; Sun Y; Koh J; Kwek XY; Ng CCY; Klanrit P; Zhang Y; Lai J; Tai DWM; Pairojkul C; Dima S; Popescu I; Hsieh SY; Yu MC; Yeong J; Kongpetch S; Jusakul A; Loilome W; Tan P; Tan J; Teh BT
Gut; 2024 May; 73(6):966-984. PubMed ID: 38050079
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of secreted proteins and glycosylation identifies prognostic features in cholangiocarcinoma.
Park DD; Xu G; Park SS; Haigh NE; Phoomak C; Wongkham S; Maverakis E; Lebrilla CB
J Cell Physiol; 2024 Mar; 239(3):e31147. PubMed ID: 37921263
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Tumorigenic Assay: A Tumor Sphere Assay for Cancer Stem Cells.
Yehya A; Bahmad H; Abou-Kheir W
Methods Mol Biol; 2024; 2777():91-98. PubMed ID: 38478338
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma.
Mustafa MZ; Nguyen VH; Le Naour F; De Martin E; Beleoken E; Guettier C; Johanet C; Samuel D; Duclos-Vallee JC; Ballot E
J Transl Med; 2016 Jan; 14():17. PubMed ID: 26774260
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma-associated oncogene homolog 1 and chemokine CCL2.
Luo Y; Li Z; Zhu H; Lu J; Lei Z; Su C; Liu F; Zhang H; Huang Q; Han S; Rao D; Wang T; Chen X; Cao H; Zhang Z; Huang W; Liang H
MedComm (2020); 2024 May; 5(5):e535. PubMed ID: 38741887
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma.
Proungvitaya S; Sombattheera S; Boonsiri P; Limpaiboon T; Wongkham S; Wongkham C; Titapun A; Proungvitaya T
Oncol Lett; 2017 Oct; 14(4):4943-4948. PubMed ID: 29085505
[TBL] [Abstract][Full Text] [Related]
8. Single-cell RNA sequencing reveals cancer stem-like cells and dynamics in tumor microenvironment during cholangiocarcinoma progression.
Golino JL; Bian J; Wang X; Fu J; Zhu XB; Yeo J; Kelly M; Escorcia FE; Cam M; Xie C
Front Cell Dev Biol; 2023; 11():1250215. PubMed ID: 38020927
[TBL] [Abstract][Full Text] [Related]
9. Defined Mathematical Relationships Among Cancer Cells Suggest Modular Growth in Tumor Progression and Highlight Developmental Features Consistent With a Para-Embryonic Nature of Cancer.
Manzo G
Front Cell Dev Biol; 2020; 8():804. PubMed ID: 32984319
[TBL] [Abstract][Full Text] [Related]
10. Metabolic vulnerability of cancer stem cells and their niche.
Marrone L; Romano S; Malasomma C; Di Giacomo V; Cerullo A; Abate R; Vecchione MA; Fratantonio D; Romano MF
Front Pharmacol; 2024; 15():1375993. PubMed ID: 38659591
[TBL] [Abstract][Full Text] [Related]
11. Global expression profile of tumor stem-like cells isolated from MMQ rat prolactinoma cell.
Su Z; Cai L; Lu J; Li C; Gui S; Liu C; Wang C; Li Q; Zhuge Q; Zhang Y
Cancer Cell Int; 2017; 17():15. PubMed ID: 28163656
[TBL] [Abstract][Full Text] [Related]
12. Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma.
Terada M; Horisawa K; Miura S; Takashima Y; Ohkawa Y; Sekiya S; Matsuda-Ito K; Suzuki A
Sci Rep; 2016 Oct; 6():34691. PubMed ID: 27698452
[TBL] [Abstract][Full Text] [Related]
13. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing.
Zheng C; Zheng L; Yoo JK; Guo H; Zhang Y; Guo X; Kang B; Hu R; Huang JY; Zhang Q; Liu Z; Dong M; Hu X; Ouyang W; Peng J; Zhang Z
Cell; 2017 Jun; 169(7):1342-1356.e16. PubMed ID: 28622514
[TBL] [Abstract][Full Text] [Related]
14. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Understanding Cholangiocarcinoma.
Kennedy L; Hargrove L; Demieville J; Francis N; Seils R; Villamaria S; Francis H
F1000Res; 2017; 6():1818. PubMed ID: 29067165
[TBL] [Abstract][Full Text] [Related]
16. Immune Regulation of the Metastatic Process: Implications for Therapy.
de Mingo Pulido A; Ruffell B
Adv Cancer Res; 2016; 132():139-63. PubMed ID: 27613132
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Banales JM; Marin JJG; Lamarca A; Rodrigues PM; Khan SA; Roberts LR; Cardinale V; Carpino G; Andersen JB; Braconi C; Calvisi DF; Perugorria MJ; Fabris L; Boulter L; Macias RIR; Gaudio E; Alvaro D; Gradilone SA; Strazzabosco M; Marzioni M; Coulouarn C; Fouassier L; Raggi C; Invernizzi P; Mertens JC; Moncsek A; Rizvi S; Heimbach J; Koerkamp BG; Bruix J; Forner A; Bridgewater J; Valle JW; Gores GJ
Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):557-588. PubMed ID: 32606456
[TBL] [Abstract][Full Text] [Related]
18. Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma.
Loeuillard E; Yang J; Buckarma E; Wang J; Liu Y; Conboy C; Pavelko KD; Li Y; O'Brien D; Wang C; Graham RP; Smoot RL; Dong H; Ilyas S
J Clin Invest; 2020 Oct; 130(10):5380-5396. PubMed ID: 32663198
[TBL] [Abstract][Full Text] [Related]
19. Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma.
Raggi C; Fiaccadori K; Pastore M; Correnti M; Piombanti B; Forti E; Navari N; Abbadessa G; Hall T; Destro A; Di Tommaso L; Roncalli M; Meng F; Glaser S; Rovida E; Peraldo-Neia C; Olaizola P; Banales JM; Gerussi A; Elvevi A; Droz Dit Busset M; Bhoori S; Mazzaferro V; Alpini G; Marra F; Invernizzi P
Am J Pathol; 2019 Oct; 189(10):2090-2101. PubMed ID: 31351075
[TBL] [Abstract][Full Text] [Related]
20. Targeting macrophages: therapeutic approaches in cancer.
Cassetta L; Pollard JW
Nat Rev Drug Discov; 2018 Dec; 17(12):887-904. PubMed ID: 30361552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
